M42, AstraZeneca sign agreement to advance prevention and precision medicine for breast cancer

M42 will conduct sequencing of hereditary breast cancer genes, with the aim of developing personalised care and prevention strategies.

Continue

Do you trust this headline?

Based on recent headline ratings, 77% of this readership currently trusts the local media, which has an average score of 89% regionally and is currently trending negative.

77%

Media Trust Score77%

Read All

In

Bill Gates